Location: Stockholm, Sweden
CIK: 0001381843 · Show all filings
Period: Q3 2021 (← Previous) (Next →)
Filing Date: Nov 8, 2021
Total Value: $66.76M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| IRWD | IRONWOOD PHARMACEUTICALS INC | 685,000 | $8.946M | 13.4% | $10.81 | +19.5% | COM CL A | 46333X108 |
| SUPN | SUPERNUS PHARMACEUTICALS INC | 335,000 | $8.934M | 13.4% | $22.36 | +20.1% | COM | 868459108 |
| ARAY | ACCURAY INC | 1,860,000 | $7.347M | 11.0% | $4.02 | -1.3% | COM | 004397105 |
| HRMY | HARMONY BIOSCIENCES HLDGS IN | 185,000 | $7.091M | 10.6% | $32.20 | 0.0% | COM | 413197104 |
| — | RIGEL PHARMACEUTICALS INC | 1,765,000 | $6.407M | 9.6% | $3.63 | — | COM NEW | 766559603 |
| — | LANNET INC | 1,775,000 | $5.325M | 8.0% | $3.00 | — | COM | 516012101 |
| UTMD | UTAH MED PRODS INC | 42,000 | $3.899M | 5.8% | $88.34 | 0.0% | COM | 917488108 |
| — | ZOGENIX INC | 220,000 | $3.342M | 5.0% | $15.19 | — | COM NEW | 98978L204 |
| ALDX | ALDEYRA THERAPEUTICS INC | 310,000 | $2.722M | 4.1% | $9.18 | 0.0% | COM | 01438T106 |
| EOLS | EVOLUS INC | 300,000 | $2.286M | 3.4% | $10.34 | 0.0% | COM | 30052C107 |
| COR | AMERISOURCEBERGEN CORP | 14,000 | $1.672M | 2.5% | $112.38 | 0.0% | COM | 03073E105 |
| BMY | BRISTOL-MYERS SQUIBB CO | 28,000 | $1.657M | 2.5% | $50.54 | +8.5% | COM | 110122108 |
| ABBV | ABBVIE INC | 15,000 | $1.618M | 2.4% | $81.92 | +18.7% | COM | 00287Y109 |
| MCK | MCKESSON CORP | 8,000 | $1.595M | 2.4% | $166.27 | +17.3% | COM | 58155Q103 |
| CAH | CARDINAL HEALTH INC | 32,000 | $1.583M | 2.4% | $48.62 | +0.5% | COM | 14149Y108 |
| URGN | UROGEN PHARMA LTD | 75,000 | $1.262M | 1.9% | $15.85 | 0.0% | COM | M96088105 |
| — | LA JOLLA PHARMACEUTICAL CO | 270,000 | $1.077M | 1.6% | $3.99 | — | COM PAR $.0001 2 | 503459604 |